Results 31 to 40 of about 3,140 (49)
An integrated, cost-effective efficient chain to deliver botulinum toxin in optimal conditions.
International Journal of Integrated Care, 2019 Introduction: Botulinum toxin is increasingly used in clinical care for a variety of conditions that include facial spasms, bleharospasms, and other abnormal movement disorders.
Marian Gomez Beldarrain +4 more
doaj +1 more source
Botulinum Toxin in the Treatment of Lingual Dystonia Induced by Speaking
Case Reports in Neurology, 2013 Primary lingual dystonia is a rare condition, especially when it is only induced by speaking. Trihexyphenidyl failed to improve the symptoms. Several case series have demonstrated the effectiveness of botulinum toxin injection for the management of focal
F. Budak +3 more
doaj +1 more source
The use of botulinum toxin in keloid scar management: a literature review
Scars, Burns & Healing, 2020 Introduction: Administration of botulinum toxin is an increasingly popular procedure in the medical and aesthetic field. There is emerging evidence that it can influence fibroblast activity and minimise tension around the scar by virtue of muscular ...
Catrin Sohrabi, Ioannis Goutos
doaj +1 more source
Contralateral Upper Limb Weakness Following Botulinum Toxin A Injection for Poststroke Spasticity
Acta Médica Portuguesa, 2020 Botulinum toxin type A has been approved for spasticity management in poststroke patients. The adverse effects are generally of two types: those related to local injection; and those related to the systemic effects from spread of the toxin ...
Alexandre Camões- Barbosa +2 more
doaj +1 more source
Botulinum neurotoxin formulations: overcoming the confusion
Clinical, Cosmetic and Investigational Dermatology, 2018 Souphiyeh Samizadeh,1 Koenraad De Boulle2 1Great British Academy of Aesthetic Medicine, London, UK; 2Aalst Dermatology Clinic, Aalst, Belgium Abstract: Botulinum toxin A is produced by anaerobic spore-forming bacteria and is used for various therapeutic ...
Samizadeh S, De Boulle K
doaj
Australasian Journal of Plastic Surgery**Background**: Synkinesis may develop following facial nerve palsy, impacting quality of life. Botulinum toxin treatment for synkinesis is commonly used, but buccinator muscle injection is less common.
Raymond Hayler +4 more
doaj +1 more source
Double Sandwich ELISA Modified Method for the Detection of Clostridium Botulinum Type E [PDF]
Journal of Advanced Biomedical Sciences, 2013 Background & Objective: A very small amount of botulinum toxin can cause death and on the other hand, there is no cure for its poison other than antitoxin.
Mohammad Ebrahim minaei, Mojtaba Saadati
doaj +2 more sources
Journal of International Medical Research, 2020 Objective A systematic review and meta-analysis was carried out to evaluate the efficacy and safety of Botulinum Toxin Type A in painful knee osteoarthritis. Methods The EMBASE and MEDLINE databases were searched to identify randomized controlled trials (
Shuchao Zhai, Botao Huang, Kai Yu
doaj +1 more source
Taiwan Journal of Ophthalmology, 2017 A 50-year-old female presented with bilateral retinitis pigmentosa (RP) and acute angle closure (AAC) with fixed mid-dilated pupil and high intraocular pressure (IOP) in the left eye following left side periorbital botulinum toxin A injection for ...
Jen-Chia Tsai
doaj +1 more source
Botulinum toxin type A in the treatment of patients with cervical dystonia
Biologics: Targets & Therapy, 2008 Allison BrashearDept of Neurology, Wake Forest University Baptist, Medical Center, Winston Salem, NC, USAAbstract: Dystonia is an involuntary movement involving twisting and turning of agonist and antagonist muscles. Cervical dystonia is isolated to neck
Allison Brashear
doaj